Human CD30/TNFRSF8 F(ab')2 (Research Grade Brentuximab Biosimilar) Antibody

Catalog #: MAB11129-FAB2 Datasheet / COA / SDS
Recombinant Monoclonal Antibody For Research Use Only
Catalog # Availability Size / Price Qty
MAB11129-FAB2-100
MAB11129-FAB2-SP
Detection of CD30/TNFRSF8 in Jurkat human acute T cell leukemia cell line by Flow Cytometry.
2 Images
Product Details
FAQs
Supplemental Products
Reviews

Human CD30/TNFRSF8 F(ab')2 (Research Grade Brentuximab Biosimilar) Antibody Summary

Species Reactivity
Human
Specificity
Detects human CD30/TNFRSF8 in direct ELISAs. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Brentuximab. This product is for research use only.
Source
Recombinant Monoclonal Human IgG1 Clone # Hu8F2
Purification
Protein A or G purified from cell culture supernatant
Immunogen
Human CD30/TNFRSF8
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Label
Unconjugated

Applications

Recommended Concentration
Sample
Flow Cytometry
0.25 µg/mL
 Jurkat human acute T cell leukemia cell line 

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Scientific Data

Flow Cytometry View Larger

Detection of CD30/TNFRSF8 in Jurkat human acute T cell leukemia cell line by Flow Cytometry. Jurkat human acute T cell leukemia cell line was stained with Human Anti-Human CD30/TNFRSF8 (Brentuximab Biosimilar) F(ab')2 Monoclonal Antibody (Catalog # MAB11129-FAB2, filled histogram) or no antibody (open histogram) followed by APC-conjugated Anti-Human IgG Secondary Antibody (F0135). View our protocol for Staining Membrane-associated Proteins.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Preparation and Storage

Reconstitution
Reconstitute at 0.5 mg/mL in sterile PBS.
Loading...
Shipping
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. *Small pack size (SP) is shipped with polar packs. Upon receipt, store it immediately at -20 to -70 °C
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: CD30/TNFRSF8

Brentuximab is a biosimilar directed against the extracellular domain of CD30.

Entrez Gene IDs
943 (Human); 21941 (Mouse); 25069 (Rat)
Alternate Names
CD30 antigen; CD30; CD30KI-1; CD30L receptor; cytokine receptor CD30; D1S166EKi-1; Ki-1 antigen; Lymphocyte activation antigen CD30; TNFRSF8; tumor necrosis factor receptor superfamily member 8; tumor necrosis factor receptor superfamily, member 8

Product Datasheets

You must select a language.

x

FAQs

No product specific FAQs exist for this product, however you may

View all Antibody FAQs
Loading...

Reviews for Human CD30/TNFRSF8 F(ab')2 (Research Grade Brentuximab Biosimilar) Antibody

There are currently no reviews for this product. Be the first to review Human CD30/TNFRSF8 F(ab')2 (Research Grade Brentuximab Biosimilar) Antibody and earn rewards!

Have you used Human CD30/TNFRSF8 F(ab')2 (Research Grade Brentuximab Biosimilar) Antibody?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review